HAILING ZHANG: Open Payments
NPI 1346331675 · BRIDGEWATER, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$466 in 30 payments from 10 companies in 2025. Trend: 2023 $351 · 2024 $586 · 2025 $466
Food & beverage: $466
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $188 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $88 |
| Bausch Health US, LLC | 3 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| Alkermes, Inc. | 1 | $20 |
| Janssen Scientific Affairs, LLC | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
Products named: VRAYLAR, CAPLYTA, WELLBUTRIN, SPRAVATO, REXULTI, ARISTADA, TRINTELLIX, FANAPT.
Industry payments across NJ — which companies pay providers there.
